Ritter Pharmaceuticals (RTTR) Stock: Climbing On Phase 3 Enrollment News

Ritter Pharmaceuticals RTTR Stock News

Ritter Pharmaceuticals Inc (NASDAQ: RTTR) is having an incredibly strong start to the trading session this morning, and for good reason. The company announced that it has completed enrollment in a key Phase 3 clinical trial. As you could imagine, the news excited investors, pushing the stock on a run for the top. Today, we’ll … Read more

Ritter Pharmaceuticals (RTTR) Stock: Flying On Clinical Data

Ritter Pharmaceuticals IncĀ (NASDAQ: RTTR) is having an overwhelmingly strong start to the trading session this morning, and for good reason. The company announced clinical data from a key Phase 2b study. Of course, the positive data led to excitement among investors and gains in the value of the stock. Today, we’ll talk about the news, … Read more

Ritter Pharmaceuticals (RTTR) Stock: Investors Aren’t Falling For Misleading Data

Ritter Pharmaceuticals Inc (NASDAQ: RTTR) Ritter Pharmaceuticals is having a rough start to the trading session, and for good reason. The company announced that a Phase 2b/3 study reached its primary endpoint. However, things aren’t always as they seem and investors seem to have caught on quickly. This lead to declines and prompted our partners … Read more